JP2022515721A5 - - Google Patents

Info

Publication number
JP2022515721A5
JP2022515721A5 JP2021534207A JP2021534207A JP2022515721A5 JP 2022515721 A5 JP2022515721 A5 JP 2022515721A5 JP 2021534207 A JP2021534207 A JP 2021534207A JP 2021534207 A JP2021534207 A JP 2021534207A JP 2022515721 A5 JP2022515721 A5 JP 2022515721A5
Authority
JP
Japan
Prior art keywords
peptide ligand
ligand according
sequence
fapα
cysteine residues
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021534207A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022515721A (ja
Filing date
Publication date
Priority claimed from GBGB1820320.8A external-priority patent/GB201820320D0/en
Application filed filed Critical
Publication of JP2022515721A publication Critical patent/JP2022515721A/ja
Publication of JP2022515721A5 publication Critical patent/JP2022515721A5/ja
Pending legal-status Critical Current

Links

JP2021534207A 2018-12-13 2019-12-13 FAPαに特異的な二環式ペプチドリガンド Pending JP2022515721A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1820320.8A GB201820320D0 (en) 2018-12-13 2018-12-13 Bicyclic peptide ligands specific for FAPalpha
GB1820320.8 2018-12-13
PCT/GB2019/053535 WO2020120979A1 (en) 2018-12-13 2019-12-13 BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR FAPα

Publications (2)

Publication Number Publication Date
JP2022515721A JP2022515721A (ja) 2022-02-22
JP2022515721A5 true JP2022515721A5 (cg-RX-API-DMAC7.html) 2022-12-19

Family

ID=65147028

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021534207A Pending JP2022515721A (ja) 2018-12-13 2019-12-13 FAPαに特異的な二環式ペプチドリガンド

Country Status (6)

Country Link
US (1) US20220008545A1 (cg-RX-API-DMAC7.html)
EP (1) EP3894005A1 (cg-RX-API-DMAC7.html)
JP (1) JP2022515721A (cg-RX-API-DMAC7.html)
CN (1) CN113507961A (cg-RX-API-DMAC7.html)
GB (1) GB201820320D0 (cg-RX-API-DMAC7.html)
WO (1) WO2020120979A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7162592B2 (ja) 2016-12-14 2022-10-28 パーデュー・リサーチ・ファウンデイション 線維芽細胞活性化タンパク質(fap)標的イメージングおよび治療
CN111118063B (zh) * 2019-12-05 2023-04-18 吉林大学 以FAPα和survivin为基础的DNA及其在制备肿瘤疫苗中的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050176622A1 (en) * 2002-09-18 2005-08-11 Kerstin Kuhn-Wache Secondary binding site of dipeptidyl peptidase IV (DPIV)
EP1452868A2 (en) 2003-02-27 2004-09-01 Pepscan Systems B.V. Method for selecting a candidate drug compound
US7374898B2 (en) * 2004-10-12 2008-05-20 The Research Foundation Of State University Of New York Peptide inhibitors against seprase
ES2428869T3 (es) 2005-01-24 2013-11-12 Pepscan Systems B.V. Compuestos de unión, compuestos inmunógenos y peptidomiméticos
US20100047170A1 (en) * 2006-01-05 2010-02-25 Denmeade Samuel R Peptide Prodrugs
JP6074574B2 (ja) 2008-02-05 2017-02-08 バイシクル セラピューティクス リミテッド 方法及び組成物
EP4706663A3 (en) * 2011-08-30 2026-05-20 Trustees Of Tufts College FAP-ACTIVATED PROTEASOME INHIBITORS USED TO TREAT SOLID TUMORS
NZ731185A (en) 2014-10-29 2024-03-22 Bicyclerd Ltd Bicyclic peptide ligands specific for mt1-mmp
WO2016146174A1 (en) * 2015-03-17 2016-09-22 Biontech Ag Compositions and methods for diagnosis and treatment of cancer
EP3615550A1 (en) * 2017-04-27 2020-03-04 BicycleTx Limited Bicyclic peptide ligands and uses thereof

Similar Documents

Publication Publication Date Title
JP2022518695A5 (cg-RX-API-DMAC7.html)
JP2022512478A5 (cg-RX-API-DMAC7.html)
JP2022514687A5 (cg-RX-API-DMAC7.html)
JP2022514255A5 (cg-RX-API-DMAC7.html)
JP2022517442A5 (cg-RX-API-DMAC7.html)
JP2022517040A5 (cg-RX-API-DMAC7.html)
JP2022513223A5 (cg-RX-API-DMAC7.html)
JP2022517698A5 (cg-RX-API-DMAC7.html)
JP2022518210A5 (cg-RX-API-DMAC7.html)
JP2022544058A5 (cg-RX-API-DMAC7.html)
JP2022532134A5 (cg-RX-API-DMAC7.html)
JP2022515720A5 (cg-RX-API-DMAC7.html)
JP2022542291A5 (cg-RX-API-DMAC7.html)
JP2011502964A5 (cg-RX-API-DMAC7.html)
JP2011530599A5 (cg-RX-API-DMAC7.html)
JP2006514104A5 (cg-RX-API-DMAC7.html)
JP2006506942A5 (cg-RX-API-DMAC7.html)
JP2005516885A5 (cg-RX-API-DMAC7.html)
JP2025186365A (ja) α4β7インテグリン拮抗薬で炎症性腸疾患を治療するための方法
ME02335B (me) Activin-actrii antagonisti i upotreba za liječenje anemije
JP2019533722A5 (cg-RX-API-DMAC7.html)
JP2017528419A5 (cg-RX-API-DMAC7.html)
JP2010518079A5 (cg-RX-API-DMAC7.html)
JP2007534698A5 (cg-RX-API-DMAC7.html)
JP2017113019A5 (cg-RX-API-DMAC7.html)